7TM Pharma AS, a Danish pharmaceutical, has raised around $22 million in a fourth-round funding from SR One Ltd, one of GlaxoSmithKline’s independent corporate healthcare venture capital fund. Other investors that have participated are Alta Partners, Baker/Tisch Investments, Dansk Innovationsinvestering, Index Ventures, Johnson & Johnson Development Corp., LD Pensions, Lombard Odier Darier Hentsch, Novo AS and Scottish Widows Investment Partnership.
High-net-worth individuals and family offices are hunting for yield, concerned about low interest rates and market volatility
Fund expects to hit its target in the first quarter of 2020 and has already made six investments
Soprome and BTC Capital also back the takeover of the security services company
Perlego offers access to online textbooks for a subscription fee of £12 per month